Matsubara, E., Bryant-Thomas, T., Pacheco, J., Henry, T. L., Poeggeler, B., Herbert, D., … Pappolla, M. A. (2003). Erratum: Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease (Journal of Neurochemistry 85 (1101-1108)). Journal of Neurochemistry, 86(5), 1312. https://doi.org/10.1046/j.1471-4159.2003.01997.x

Matsubara, E., T. Bryant-Thomas, J. Pacheco, T. L. Henry, B. Poeggeler, D. Herbert, F. Cruz-Sanchez, et al. “Erratum: Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease (Journal of Neurochemistry 85 (1101-1108)).” Journal of Neurochemistry 86, no. 5 (January 1, 2003): 1312. https://doi.org/10.1046/j.1471-4159.2003.01997.x.

Matsubara E, Bryant-Thomas T, Pacheco J, Henry TL, Poeggeler B, Herbert D, et al. Erratum: Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease (Journal of Neurochemistry 85 (1101-1108)). Journal of Neurochemistry. 2003 Jan 1;86(5):1312.

Matsubara, E., et al. “Erratum: Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease (Journal of Neurochemistry 85 (1101-1108)).” Journal of Neurochemistry, vol. 86, no. 5, Jan. 2003, p. 1312. Scopus, doi:10.1046/j.1471-4159.2003.01997.x.

Matsubara E, Bryant-Thomas T, Pacheco J, Henry TL, Poeggeler B, Herbert D, Cruz-Sanchez F, Chyan YJ, Smith MA, Perry G, Chain DG, Neria E, Shoji M, Abe K, Leone A, Grundke-Iqbal I, Wilson GL, Ghiso J, Williams C, Refolo LM, Pappolla MA. Erratum: Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease (Journal of Neurochemistry 85 (1101-1108)). Journal of Neurochemistry. 2003 Jan 1;86(5):1312.